AC Immune (ACIU)
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention...
- Open
- 2.910
- High
- 2.940
- Low
- 2.820
- Prev. Close
- 2.930
- Volume
- 155.63K
- Turnover
- 445.46K
- Avg Price
- 2.862
- Bid/Ask Ratio
- --
- Amplitude
- 4.10%
- 52wk High
- 4.000
- Volume Ratio
- 0.83
- Turnover Ratio
- 0.38%
AC Immune Analyst Rating
View moreForecast & Rating
Aug 21, 2026Price forecast
$8.61201.21%
Forecast & RatingStrong buy
4analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Tip Ranks · 1 day ago, 11:28 AM
AC Immune Calls October EGM to Add Veteran Biopharma Financier Tom Graney to Board
- benzinga_article · Aug 27 at 12:05 PM
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Global Report · Aug 25 at 10:12 AM
Signals Emerge from Recent Biotech and Small-Cap Moves
- benzinga_article · Aug 20 at 04:32 PM
AC Immune Says Early Data from Anti-Inflammatory Drug Gives Wider Clinical Momentum for Pipeline
- PUBT · Aug 20 at 11:00 AM
AC Immune reports positive interim Phase 1 data for NLRP3 inhibitor ACI-19764
